corporate_fare
Skyhawk Therapeutics Inc.
- Address
- 35 Gatehouse Drive
Sponsor Overview
assignment
1
sponsored trial
science
0
molecules
location_city
9
research centres
public
2
countries
person_search
10
investigators
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 2/3 Randomized, Double‑Blind, Placebo‑Controlled, Dose‑Ranging Study of SKY‑0515 in Adults with Huntington’s Disease |  Germany Spain | Not Yet Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 9 sites collaborated multiple times
This sponsor has worked with 9 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases1 trial449 other sponsors
Partnered Research Centres
9 centreslocation_city
assignment1047Charite Universitaetsmedizin Berlin KöR
- Address
- Hindenburgdamm 30, Lichterfelde, 12203 Berlin
location_city
assignment1Deutsches Zentrum für Neurodegenerative Erkrankungen e. V.
- Address
- Venusberg-Campus 1, Gebäude 99, 53127 Bonn
location_city
assignment5George-Huntington-Institut GmbH
- Address
- Wilhelm-Schickard-Strasse 15, Sentrup, 48149 Munster
location_city
assignment1049Hospital Clinic De Barcelona
- Address
- Calle Villarroel 170, 08036 Barcelona
location_city
assignment735Hospital De La Santa Creu I Sant Pau
- Address
- Carrer De San Quinti 89, 08041 Barcelona
location_city
assignment1Huntington-Zentrum Lübeck
- Address
- Universitätsklinikum Schleswig-Holstein, Ratzeburger Allee 160, 23538 Lübeck
Page 1 of 2
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Skyhawk Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.